Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TAPENTADOL Cause Skin atrophy? 7 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Skin atrophy have been filed in association with TAPENTADOL (Nucynta). This represents 0.0% of all adverse event reports for TAPENTADOL.

7
Reports of Skin atrophy with TAPENTADOL
0.0%
of all TAPENTADOL reports
0
Deaths
0
Hospitalizations

How Dangerous Is Skin atrophy From TAPENTADOL?

Of the 7 reports.

Is Skin atrophy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TAPENTADOL. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does TAPENTADOL Cause?

Death (11,560) Toxicity to various agents (9,617) Overdose (5,843) Drug abuse (1,566) Drug dependence (1,019) Drug withdrawal syndrome neonatal (945) Accidental overdose (693) Drug ineffective (633) Pain (436) Nausea (434)

What Other Drugs Cause Skin atrophy?

DUPILUMAB (262) PREDNISONE (258) ADALIMUMAB (205) METHOTREXATE (191) ETANERCEPT (139) CLOBETASOL (123) SECUKINUMAB (121) IBRUTINIB (112) TRIAMCINOLONE ACETONIDE (110) HYDROCORTISONE (106)

Which TAPENTADOL Alternatives Have Lower Skin atrophy Risk?

TAPENTADOL vs TAPINAROF TAPENTADOL vs TARCEVA TAPENTADOL vs TARLATAMAB TAPENTADOL vs TARLATAMAB-DLLE TAPENTADOL vs TASIGNA

Related Pages

TAPENTADOL Full Profile All Skin atrophy Reports All Drugs Causing Skin atrophy TAPENTADOL Demographics